SGRT-based stereotactic body radiotherapy for lung cancer setup accuracy and margin of the PTV

被引:3
|
作者
Guo, Hai-Liang [1 ]
Wu, Wei-Wei [2 ]
Huan, Yan [3 ]
Zhang, Huai-Wen [4 ,5 ]
机构
[1] Gannan Med Univ, Affiliated Hosp 1, Dept Oncol, Ganzhou, Peoples R China
[2] Gannan Med Univ, Affiliated Canc Hosp, GanZhou Canc Hosp, Dept Radiotherapy, Ganzhou, Peoples R China
[3] Peoples Hosp Qianxinan Buyi & Miao Minor Autonomou, Dept Oncol, Qian Xinan, Peoples R China
[4] Nanchang Med Coll, Affiliated Hosp 2, NHC Key Lab Personalized Diag & Treatment Nasophar, Dept Radiotherapy,Jiangxi Canc Hosp, Nanchang 330029, Peoples R China
[5] Third Peoples Hosp Jingdezhen, Dept Oncol, Jingdezhen, Peoples R China
来源
关键词
intrafraction error; lung cancer; stereotactic radiotherapy; surface-guided radiation therapy; COMPUTED-TOMOGRAPHY; RADIATION-THERAPY; LOCALIZATION; SYSTEMS; SBRT;
D O I
10.1002/acm2.14195
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Surface-guided radiation therapy (SGRT, AlignRT) was used to analyze motion during stereotactic body radiotherapy (SBRT) in lung cancer patients and to explore the margin of the planning target volume (PTV).Methods: The residual errors of the AlignRT were evaluated based on grayscale cone-beam computed tomography registration results before each treatment. AlignRT log file was used to analyze the correlation between the frequency and longest duration of errors larger than 2 mm and lasting longer than 2 s and maximum error with age and treatment duration. The displacement value at the end of treatment, the average displacement value, and the 95% probability density displacement interval were defined as intrafraction errors, and PTV1, PTV2, PTV3 were calculated by Van Herk formula or Z score analysis. Organ dosimetric differences were compared after the experience-based margin was replaced with PTV3.Results: The interfraction residual errors were Vrt(0), 0.06 +/- 0.18 cm; Lng(0), -0.03 +/- 0.19 cm; Lat(0), 0.02 +/- 0.15 cm; Pitch(0), 0.23 +/- 0.7 degrees; Roll(0), 0.1 +/- 0.69 degrees; Rtn(0), -0.02 +/- 0.79 degrees. The frequency, longest duration and maximum error in vertical direction were correlated with treatment duration (r = 0.404, 0.353, 0.283, p < 0.05, respectively). In the longitudinal direction, the frequency was correlated with age and treatment duration (r = 0.376, 0.283, p < 0.05, respectively), maximum error was correlated with age (r = 0.4, P < 0.05). Vertical, longitudinal, lateral margins of PTV1, PTV2, PTV3 were 2 mm, 4 mm, 2 mm; 2 mm, 2 mm, 2 mm, 3 mm, 5 mm, 3 mm, respectively. After replacing the original PTV, mean lung dose (MLD), 2-cm(3) chest wall dose (CD), lung V-20 decreased by 0.2 Gy, 2.1 Gy, 0.5%, respectively (p < 0.05).Conclusion: AlignRT can be used for interfraction setup and monitoring intrafraction motion. It is more reasonable to use upper and lower limits of the 95% probability density interval as an intrafraction error.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Predictive power of PTV volume for choosing manual or automatic planning in lung stereotactic body radiotherapy
    Duan, Yanhua
    Feng, Aihui
    Liu, Ning
    Shao, Yan
    Kong, Qing
    Zhou, Tao
    Xu, Zhiyong
    JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES, 2024, 17 (03)
  • [22] Planning target volume (PTV) reduction for gated stereotactic body radiotherapy(SBRT) of lung tumors
    Kraus, K.
    Wilkens, J. J.
    Oechsner, M.
    Combs, S. E.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S893 - S893
  • [23] Stereotactic body radiotherapy in lung cancer: a contemporary review
    Csiki, Emese
    Simon, Mihaly
    Papp, Judit
    Barabas, Marton
    Mikaczo, Johanna
    Gal, Kristof
    Sipos, David
    Kovacs, Arpad
    PATHOLOGY & ONCOLOGY RESEARCH, 2024, 30
  • [24] Current status of stereotactic body radiotherapy for lung cancer
    Yasushi Nagata
    Yukinori Matsuo
    Kenji Takayama
    Yoshiki Norihisa
    Takashi Mizowaki
    Michihide Mitsumori
    Keiko Shibuya
    Shinsuke Yano
    Yuichiroh Narita
    Masahiro Hiraoka
    International Journal of Clinical Oncology, 2007, 12 : 3 - 7
  • [25] Current status of stereotactic body radiotherapy for lung cancer
    Nagata, Yasushi
    Matsuo, Yukinori
    Takayama, Kenji
    Norihisa, Yoshiki
    Mizowaki, Takashi
    Mitsumori, Michibide
    Shibuya, Keiko
    Yano, Shinsuke
    Narita, Yuichiroh
    Hiraoka, Masahiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (01) : 3 - 7
  • [26] Stereotactic Body Radiotherapy for Early Stage Lung Cancer
    Nagata, Yasushi
    CANCER RESEARCH AND TREATMENT, 2013, 45 (03): : 155 - 161
  • [27] Complications from Stereotactic Body Radiotherapy for Lung Cancer
    Kang, Kylie H.
    Okoye, Christian C.
    Patel, Ravi B.
    Siva, Shankar
    Biswas, Tithi
    Ellis, Rodney J.
    Yao, Min
    Machtay, Mitchell
    Lo, Simon S.
    CANCERS, 2015, 7 (02): : 981 - 1004
  • [28] Lung Stereotactic Body Radiotherapy in a Community Cancer Center
    Golden, Nanialei
    Ting, Joseph
    Easterling, Stephen
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 202 - 203
  • [29] Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer
    Abbas, Ghulam
    Danish, Adnan
    Krasna, Mark J.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (03) : 553 - +
  • [30] 4DCT and CBCT based PTV margin in Stereotactic Body Radiotherapy(SBRT) of non-small cell lung tumor adhered to chest wall or diaphragm
    Yi Li
    Jing-lu Ma
    Xin Chen
    Feng-wen Tang
    Xiao-zhi Zhang
    Radiation Oncology, 11